Next Article in Journal

Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors

Next Article in Special Issue

Is the Efficacy of Adding Ramucirumab to Docetaxel Related to a History of Immune Checkpoint Inhibitors in the Real-World Clinical Practice?

Previous Article in Journal

Advanced Bile Duct Cancers: A Focused Review on Current and Emerging Systemic Treatments

Previous Article in Special Issue

Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessEditor’s ChoiceArticle

Article Versions Notes

Cancers 2022, 14(7), 1801; https://doi.org/10.3390/cancers14071801

Action	Date	Notes	Link
article xml file uploaded	1 April 2022 13:51 CEST	Original file	-
article xml uploaded.	1 April 2022 13:51 CEST	Update	https://www.mdpi.com/2072-6694/14/7/1801/xml
article pdf uploaded.	1 April 2022 13:51 CEST	Version of Record	https://www.mdpi.com/2072-6694/14/7/1801/pdf
article supplementary file uploaded.	1 April 2022 13:51 CEST	-	https://www.mdpi.com/2072-6694/14/7/1801#supplementary
article html file updated	1 April 2022 13:53 CEST	Original file	-
article html file updated	2 August 2022 16:58 CEST	Update	https://www.mdpi.com/2072-6694/14/7/1801/html

Back to TopTop